|
|
 | | | |
- close
- close
- close
- close
Flightglobal
May 5
Comment
Failure to redistribute passengers on an Airbus A320 led the aircraft to strike its tail on take-off from Verona, Italian investigation agency the ANSV has found.
Globe Newswire
Mar 8
Comment
NEW YORK, March 8, 2010 (GLOBE NEWSWIRE) -- The NASDAQ Stock Market announced today that it will delist the common stock of Anesiva, Inc. Anesiva, Inc.'s stock was suspended on January 06, 2010 and has not traded on NASDAQ since that time. NASDAQ
Globe Newswire
Jan 5
Comment
CALGARY, Alberta, Jan. 5, 2010 (GLOBE NEWSWIRE) -- Emerging Stock Report, a leading provider of sector specific independent investment research, today initiated coverage on Anesiva, Inc. (Nasdaq:ANSV). Emerging Stock Report is currently offering a
FierceBiotech
Jan 4
Comment
Anesiva didn't make it intact into the new year. The South San Francisco-based company announced on New Year's Eve that it couldn't complete a planned merger with Arcion Therapeutics and instead would cease operations and file for...
Reuters
Dec 31
Comment
Anesiva Inc , a
developer of pharmaceutical products for chronic pain, said on
Thursday it will file for bankruptcy after it was unable to
complete a proposed merger with Arcion Therapeutics Inc.
StreetInsider.com
Dec 9
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Anesiva+%28ANSV%29+Sells+Certain+Zingo+Injection+System+Rights+to+Powder+Pharma+and+Lee%27s+Pharma/5172751.html for the full story.
FierceBiotech
Aug 5
Comment
Struggling pain management company Anesiva has been rescued from possible bankruptcy through a merger with Baltimore-based Arcion Therapeutics, a privately held company. The combined company will be known as Arcion Therapeutics. Arcion and...
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
TOP CONTRIBUTORS
Company Overview
Anesiva, Inc. was incorporated on January 19, 1999 in Delaware. Anesiva is a biopharmaceutical company focused on the development and commercialization of novel therapeutic treatments for pain management. Their portfolio of products includes:
- Zingo™ (lidocaine hydrochloride monohydrate) powder intradermal injection system, which was approved by the Food and Drug Administration, the FDA, in August 2007 to reduce the pain associated with peripheral IV insertions or blood draws in children three to 18 years of age.
- Adlea™, a long-acting, site-specific, non-opioid analgesic, is being developed for moderate to severe pain, and has completed multiple Phase 2 trials in post-surgical, musculoskeletal and neuropathic pain and a Phase 3 trial in bunionectomy.
Zingo and Adlea are different drugs, each with its own mechanisms of action. Zingo is comprised of microcrystals of lidocaine delivered into the skin by compressed gas. Zingo employs a proprietary needle-free dispenser. Adlea is a novel non-opioid drug candidate that is a vanilloid receptor 1 agonist, or TRPV1 agonist, based on the compound capsaicin which provides analgesia for between two and three months. [1]
References
| |||||||
